Kawasaki disease: Guidelines of Italian Society of Pediatrics, part II - Treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks

Alessandra Marchesi, Isabella Tarissi De Jacobis, Donato Rigante, Alessandro Rimini, Walter Malorni, Giovanni Corsello, Grazia Bossi, Sabrina Buonuomo, Fabio Cardinale, Elisabetta Cortis, Fabrizio De Benedetti, Andrea De Zorzi, Marzia Duse, Domenico Del Principe, Rosa Maria Dellepiane, Livio D'Isanto, Maya El Hachem, Susanna Esposito, Fernanda Falcini, Ugo GiordanoMaria Cristina Maggio, Savina Mannarino, Gianluigi Marseglia, Silvana Martino, Giulia Marucci, Rossella Massaro, Christian Pescosolido, Donatella Pietraforte, Maria Cristina Pietrogrande, Patrizia Salice, Aurelio Secinaro, Elisabetta Straface, Alberto Villani

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.

Original languageEnglish
Article number103
JournalItalian Journal of Pediatrics
Volume44
Issue number1
DOIs
Publication statusPublished - Aug 30 2018

Fingerprint

Mucocutaneous Lymph Node Syndrome
Life Style
Guidelines
Pediatrics
Therapeutics

Keywords

  • Aspirin
  • Child
  • Coronary artery abnormalities
  • Innovative biotechnologies
  • Intravenous immunoglobulin
  • Kawasaki disease
  • Personalized medicine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Kawasaki disease : Guidelines of Italian Society of Pediatrics, part II - Treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks. / Marchesi, Alessandra; Tarissi De Jacobis, Isabella; Rigante, Donato; Rimini, Alessandro; Malorni, Walter; Corsello, Giovanni; Bossi, Grazia; Buonuomo, Sabrina; Cardinale, Fabio; Cortis, Elisabetta; De Benedetti, Fabrizio; De Zorzi, Andrea; Duse, Marzia; Del Principe, Domenico; Dellepiane, Rosa Maria; D'Isanto, Livio; El Hachem, Maya; Esposito, Susanna; Falcini, Fernanda; Giordano, Ugo; Maggio, Maria Cristina; Mannarino, Savina; Marseglia, Gianluigi; Martino, Silvana; Marucci, Giulia; Massaro, Rossella; Pescosolido, Christian; Pietraforte, Donatella; Pietrogrande, Maria Cristina; Salice, Patrizia; Secinaro, Aurelio; Straface, Elisabetta; Villani, Alberto.

In: Italian Journal of Pediatrics, Vol. 44, No. 1, 103, 30.08.2018.

Research output: Contribution to journalReview article

Marchesi, Alessandra ; Tarissi De Jacobis, Isabella ; Rigante, Donato ; Rimini, Alessandro ; Malorni, Walter ; Corsello, Giovanni ; Bossi, Grazia ; Buonuomo, Sabrina ; Cardinale, Fabio ; Cortis, Elisabetta ; De Benedetti, Fabrizio ; De Zorzi, Andrea ; Duse, Marzia ; Del Principe, Domenico ; Dellepiane, Rosa Maria ; D'Isanto, Livio ; El Hachem, Maya ; Esposito, Susanna ; Falcini, Fernanda ; Giordano, Ugo ; Maggio, Maria Cristina ; Mannarino, Savina ; Marseglia, Gianluigi ; Martino, Silvana ; Marucci, Giulia ; Massaro, Rossella ; Pescosolido, Christian ; Pietraforte, Donatella ; Pietrogrande, Maria Cristina ; Salice, Patrizia ; Secinaro, Aurelio ; Straface, Elisabetta ; Villani, Alberto. / Kawasaki disease : Guidelines of Italian Society of Pediatrics, part II - Treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks. In: Italian Journal of Pediatrics. 2018 ; Vol. 44, No. 1.
@article{51fd1429ef5b4740bdc1315f2ac9cba6,
title = "Kawasaki disease: Guidelines of Italian Society of Pediatrics, part II - Treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks",
abstract = "This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.",
keywords = "Aspirin, Child, Coronary artery abnormalities, Innovative biotechnologies, Intravenous immunoglobulin, Kawasaki disease, Personalized medicine",
author = "Alessandra Marchesi and {Tarissi De Jacobis}, Isabella and Donato Rigante and Alessandro Rimini and Walter Malorni and Giovanni Corsello and Grazia Bossi and Sabrina Buonuomo and Fabio Cardinale and Elisabetta Cortis and {De Benedetti}, Fabrizio and {De Zorzi}, Andrea and Marzia Duse and {Del Principe}, Domenico and Dellepiane, {Rosa Maria} and Livio D'Isanto and {El Hachem}, Maya and Susanna Esposito and Fernanda Falcini and Ugo Giordano and Maggio, {Maria Cristina} and Savina Mannarino and Gianluigi Marseglia and Silvana Martino and Giulia Marucci and Rossella Massaro and Christian Pescosolido and Donatella Pietraforte and Pietrogrande, {Maria Cristina} and Patrizia Salice and Aurelio Secinaro and Elisabetta Straface and Alberto Villani",
year = "2018",
month = "8",
day = "30",
doi = "10.1186/s13052-018-0529-2",
language = "English",
volume = "44",
journal = "Italian Journal of Pediatrics",
issn = "1720-8424",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Kawasaki disease

T2 - Guidelines of Italian Society of Pediatrics, part II - Treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks

AU - Marchesi, Alessandra

AU - Tarissi De Jacobis, Isabella

AU - Rigante, Donato

AU - Rimini, Alessandro

AU - Malorni, Walter

AU - Corsello, Giovanni

AU - Bossi, Grazia

AU - Buonuomo, Sabrina

AU - Cardinale, Fabio

AU - Cortis, Elisabetta

AU - De Benedetti, Fabrizio

AU - De Zorzi, Andrea

AU - Duse, Marzia

AU - Del Principe, Domenico

AU - Dellepiane, Rosa Maria

AU - D'Isanto, Livio

AU - El Hachem, Maya

AU - Esposito, Susanna

AU - Falcini, Fernanda

AU - Giordano, Ugo

AU - Maggio, Maria Cristina

AU - Mannarino, Savina

AU - Marseglia, Gianluigi

AU - Martino, Silvana

AU - Marucci, Giulia

AU - Massaro, Rossella

AU - Pescosolido, Christian

AU - Pietraforte, Donatella

AU - Pietrogrande, Maria Cristina

AU - Salice, Patrizia

AU - Secinaro, Aurelio

AU - Straface, Elisabetta

AU - Villani, Alberto

PY - 2018/8/30

Y1 - 2018/8/30

N2 - This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.

AB - This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations. Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.

KW - Aspirin

KW - Child

KW - Coronary artery abnormalities

KW - Innovative biotechnologies

KW - Intravenous immunoglobulin

KW - Kawasaki disease

KW - Personalized medicine

UR - http://www.scopus.com/inward/record.url?scp=85052725593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052725593&partnerID=8YFLogxK

U2 - 10.1186/s13052-018-0529-2

DO - 10.1186/s13052-018-0529-2

M3 - Review article

AN - SCOPUS:85052725593

VL - 44

JO - Italian Journal of Pediatrics

JF - Italian Journal of Pediatrics

SN - 1720-8424

IS - 1

M1 - 103

ER -